Evidence map›Paper›PMID 22034493›Full record

ArticleCirculation research2012

B-cell aortic homing and atheroprotection depend on Id3.

Amanda C Doran, Michael J Lipinski, Stephanie N Oldham, James C Garmey, Kirsti A Campbell, Marcus D Skaflen, Alexis Cutchins, Daniel J Lee, David K Glover, Kimberly A Kelly and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  7. Review
  8. Article
  9. HIV Infection Drives Foam Cell Formation via NLRP3 Inflammasome Activation.International journal of molecular sciences · 2024
    Article
  10. Review
  11. Article
  12. Atherosclerosis antigens as targets for immunotherapy.Nature cardiovascular research · 2023
    Review
  13. Human circulating CD24Nature cardiovascular research · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Amanda C DoranUniversity of Virginia, PO Box 801394, 415 Lane Rd, Charlottesville, VA 22908, USA. cam8c@virginia.edu
Michael J Lipinski
Stephanie N Oldham
James C Garmey
Kirsti A Campbell
Marcus D Skaflen
Alexis Cutchins
Daniel J Lee
David K Glover
Kimberly A Kelly
Elena V Galkina
Klaus Ley
Joseph L Witztum
Sotirios Tsimikas
Timothy P Bender
Coleen A McNamara
La Jolla Institute for Immunology · USEastern Virginia Medical School · US

Funding

ROLE OF LIPOXYGENASES IN ATHEROGENESIS IN DIABETES MELLITUSP01HL055798 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HEDRICK, CATHERINE C · 1995 to 2016
$28.4M
Transcriptional GenomicsP01HL088093 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WITZTUM, JOSEPH L. · 2008 to 2018
$26.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
Local B-1 Regulation of AtherosclerosisR01HL136098 · NHLBI · UNIVERSITY OF VIRGINIA · PI MCNAMARA, COLEEN A · 2017 to 2020
$3.1M
MONOCYTE ADHESION TO ATHEROMA IN GENE TARGETED MICER01HL058108 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LEY, KLAUS F. · 1997 to 2009
$2.6M
Vascular Biology ResearchT32HL007355 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MCNAMARA, COLEEN A · 1985 to 2009
$2.6M
ID3 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATIONR01HL062522 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MCNAMARA, COLEEN A · 1999 to 2008
$2.1M
Development of a Vaccine Approach to Inhibit AtherosclerosisR01HL086559 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WITZTUM, JOSEPH L. · 2007 to 2011
$2.0M
Genetic Regulation of B Lymphocyte Aortic Homing and AtheroprotectionR01HL107490 · NHLBI · UNIVERSITY OF VIRGINIA · PI MCNAMARA, COLEEN A · 2011 to 2014
$1.5M
Id3/B Lymphocytes and AtherosclerosisR01HL096447 · NHLBI · UNIVERSITY OF VIRGINIA · PI MCNAMARA, COLEEN A · 2009 to 2010
$1.0M
NHLBI NIH HHS HL096447-01A1NHLBI NIH HHS P01 HL055798NHLBI NIH HHS P01 HL088093NHLBI NIH HHS P01 HL55798NHLBI NIH HHS R01 HL058108NHLBI NIH HHS R01 HL062522NHLBI NIH HHS R01 HL086559NHLBI NIH HHS R01 HL096447NHLBI NIH HHS R01 HL107490NHLBI NIH HHS R01 HL136098NHLBI NIH HHS R01HL58108NHLBI NIH HHS R01HL62522NHLBI NIH HHS T32 HL007355
6 · The paper itself

Abstract

rationaleB cells are abundant in the adventitia of normal and diseased vessels. Yet, the molecular and cellular mechanisms mediating homing of B cells to the vessel wall and B-cell effects on atherosclerosis are poorly understood. Inhibitor of differentiation-3 (Id3) is important for atheroprotection in mice and polymorphism in the human ID3 gene has been implicated as a potential risk marker of atherosclerosis in humans. Yet, the role of Id3 in B-cell regulation of atherosclerosis is unknown.

objectiveTo determine if Id3 regulates B-cell homing to the aorta and atheroprotection and identify molecular and cellular mechanisms mediating this effect. METHODS AND

resultsLoss of Id3 in Apoe(-/-) mice resulted in early and increased atherosclerosis. Flow cytometry revealed a defect in Id3(-/-) Apoe(-/-) mice in the number of B cells in the aorta but not the spleen, lymph nodes, and circulation. Similarly, B cells transferred from Id3(-/-) Apoe(-/-) mice into B-cell-deficient mice reconstituted spleen, lymph node, and blood similarly to B cells from Id3(+/+) Apoe(-/-) mice, but aortic reconstitution and B-cell-mediated inhibition of diet-induced atherosclerosis was significantly impaired. In addition to retarding initiation of atherosclerosis, B cells homed to regions of existing atherosclerosis, reduced macrophage content in plaque, and attenuated progression of disease. The chemokine receptor CCR6 was identified as an important Id3 target mediating aortic homing and atheroprotection.

conclusionsTogether, these results are the first to identify the Id3-CCR6 pathway in B cells and demonstrate its role in aortic B-cell homing and B-cell-mediated protection from early atherosclerosis.

Indexed as

AnimalsAortaApolipoproteins EAtherosclerosisB-LymphocytesCell MovementDietDisease Models, AnimalDisease ProgressionIncidenceInhibitor of Differentiation ProteinsMiceMice, KnockoutPlaque, AtheroscleroticReceptors, CCR6Signal TransductionApolipoproteins ECCR6 protein, mouseIdb3 protein, mouseInhibitor of Differentiation ProteinsReceptors, CCR6

Identifiers

PMID22034493
PMCPMC3253259
OpenAlexW2120896519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.